curriculum vitae - Azienda Ospedaliera di Padova

CURRICULUM VITAE 

INFORMAZIONI PERSONALI 

Nome ALIDA LINDA PATRIZIA CAFORIO 

Data di nascita 05/06/1959 

Qualifica I Fascia 

Amministrazione AZIENDA OSPEDALIERA DI PADOVA 

Incarico attuale Staff - Cardiologia 

Numero telefonico 

dell’ufficio 

0498212348 

Fax dell’ufficio 0498761764 

E-mail istituzionale alida.caforio@unipd.it 

TITOLI DI STUDIO E 

PROFESSIONALI ED 

ESPERIENZE LAVORATIVE 

Titolo di studio Laurea in Medicina e Chirurgia (110/110 e lode) Università di 

Pisa 

Altri titoli di studio e 

professionali 

- Diploma di specializzazione in Malattie dell'Apparato 

Cardiovascolare (70/70 e lode)Università di Pisa 

- Dottorato di Ricerca (PhD) nella Facultà di Medicina, 

specialità Immunologia Cardiovascolare, St. George's 

Hospital Medical School Università di Londra 

- Allievo della Classe di Scienze Sperimentali e Applicate, 

Settore di Medicina e Chirurgia,Scuola Superiore di Studi 

Universitari e di Perfezionamento S. Anna, Pisa 

- Diploma di perfezionamento della Classe di Scienze 

Sperimentali e Applicate, Settore di Medicina e Chirurgia 

(70/70 e lode), Scuola Superiore di Studi Universitari e di 

Perfezionamento S. Anna, Pisa 

- 1989-90 British Heart Foundation Research Fellowship 

- 1990-1991 Borsa di studio del Ministero dell' Università e 

della Ricerca Scientifica e Tecnologica (MURST) per la 

frequenza di corsi di specializzazione e ricerca presso 

istituzioni estere di livello universitario 

- 1991-1992 European Society of Cardiology Research 

Fellowship 

- 1993 Borsa di studio CNR Progetto Finalizzato "FAT.MA" 

- 1994-95 Borsa di studio Ministero dell' Università e della 

Ricerca Scientifica e Tecnologica (MURST) post-dottorato 

di ricerca 

1


Esperienze professionali 

(incarichi ricoperti) 

Capacità linguistiche 

Capacità nell’uso delle 

tecnologie 

Altro (partecipazione a 

convegni e seminari, 

pubblicazioni, 

collaborazione a riviste, 

- 1996 Premio "Attilio Reale" per la Ricerca di base in 

Cardiologia; 

- 2003 Premio Societa’ Italiana di Cardiologia“SCHOLAR IN 

CARDIOLOGIA”- 

- 1988-92 Assistente a tempo pieno di Cardiologia 

Department of Cardiological Sciences (Prof. Alan J Camm, 

Dr William J McKenna), St. George's Hospital,Università di 

Londra (servizio sanitario prestato all'estero riconosciuto 

con decreto del Ministero della Sanita' del 17/12/1994) 

- 1988-92 Ricercatrice (Clinical Research Fellow) 

Department of Cardiological Sciences (Prof. Alan J Camm, 

Dr William J McKenna)St. George's Hospital Medical 

School,Università di Londra 

- 1987 Ricercatrice onoraria (Honorary Research Fellow) 

Cardiovascular Research Unit, Royal Postgraduate Medical 

School,Hammersmith Hospital, Università di Londra, (Prof. 

Attilio Maseri, Dr William J McKenna) 

- 1993-Lettrice onoraria (Honorary Lecturer) Department of 

Cardiological Sciences St. George's Hospital Medical 

School,Università di Londra (Prof. William J McKenna) 

- 1999-Professore a Contratto Scuola di Specializzazione in 

Cardiologia I,Università degli Studi di Padova (Prof. Sabino 

Iliceto) 

- 2006- Titolare di Insegnamento (Esperto Esterno) In 

Cardiologia Clinica su: “IMMUNOLOGIA 

CARDIOVASCOLARE” Scuola di Specializzazione in 

Cardiologia I, IV anno Università degli Studi di Padova 

(Prof. Sabino Iliceto) 

- Dal 1997 al 2003 Responsabile Cardiologo del 

Day-Hospital Trapianti della Cardiochirurgia Azienda 

Universita’ di Padova, dedicato al follow-up di circa 500 

pazienti cardiotrapiantati, comprendente anche pazienti in 

eta’ pediatrica (Prof D Casarotto, Prof S Dalla Volta). 

- Incarico dirigenziale di alta specializzazione afferente 

all’U.O. di Cardiologia: “MIOCARDITI” Azienda 

Ospedaliera-Università di Padova (Prof. Sabino Iliceto) - 

AZIENDA OSPEDALIERA DI PADOVA 

Lingua Livello Parlato Livello Scritto 

Inglese Eccellente Eccellente 

- Utilizzo corrente di PC (grafica, statistica, word-processing, 

ricerche bibliografiche, aggiornamento) ed attrezzature 

biomedicali per la diagnostica cardiologica non invasiva 

(con particolare riferimento ad elettrocardiografia, ed 

ecocardiografia). 

- LAVORI PER EXTENSO: 122 (Dei quali con indicizzati in 

Medline 97, IMPACT FACTOR TOTALE 469.057 (Impact 

Factor totale calcolato da Journal citation reports-science 

2


ecc., ed ogni altra 

informazione che il 

dirigente ritiene di dover 

pubblicare) 

edition del 2007). LAVORI BREVI ED ABSTRACTS DI 

RELAZIONI TENUTE A CONGRESSI NAZIONALI ED 

INTERNAZIONALI: 258; RELAZIONI SU INVITO A 

CONGRESSI, CONFERENZE, CORSI DI 

AGGIORNAMENTO: 118. 

- REVISORE RIVISTE SCIENTIFICHE NAZIONALI ED 

INTERNAZIONALI - Italian Heart Journal -J Cardiovasc 

Med - Heart - European Heart Journal - European Journal 

of Heart Failure - International Journal of Cardiology - 

Journal of the American College of Cardiology - Journal of 

cellular and Molecular Medicine - Journal of Heart and Lung 

Transplantation - Journal of Internal Medicine - Journal of 

Immunological methods - Circulation - Clinical Cardiology - 

Clinical and Experimental Immunology - Nature 

Cardiovascular Medicine 

- ISCRIZIONE A SOCIETA': Societa' Italiana di Cardiologia- 

Socio ordinario 1985. European Society of 

Cardiology-Member of Working Group on "Myocardial and 

Pericardial Diseases " 1990-2009. European Society of 

Cardiology-Fellow 1995. International Society for Heart and 

Lung Transplantation –Member 1996. Associazione 

Nazionale Medici Cardiologi Ospedalieri (A.N.M.C.O.) 

–Fellow 2000. Societa' Italiana di Cardiologia-Membro del 

Nucleo del Gruppo di Studio su: "Funzione Miocardica, 

cardiomiopatie e Scompenso Cardiaco" 2003-2007. 

Federazione Italiana di Cardiologia-Membro del Nucleo del 

Gruppo di Studio su: "Scompenso Cardiaco" 2008. 

Federazione Italiana di Cardiologia-Vice-Coordinatore del 

Gruppo di Studio su: " Cardiomiopatie " 2008. 

- LAVORI PER EXTENSO 1)Sighieri C, Cecchini M, Zucchi 

R, Petronio AS, Gherarducci G, Caforio ALP, Poddighe R, 

Mariani M: Embolia sistemica nei portatori di protesi 

valvolari cardiache: fattori predisponenti e influenza della 

terapia anticoagulante. Cardiologia 1985; 30: 617-622 

- 2)Frennaux MP, Porter A, Caforio ALP, Odawara H, 

Counihan PJ, McKenna WJ: Determinants of exercise 

capacity in hypertrophic cardiomyopathy. J Am Coll Cardiol 

1989; 13: 1521-1526 I.F. 11.054 

- 3) Caforio ALP, Rossi B, Risaliti R, Siciliano G, Marchetti A, 

Angelini C, Crea F, Mariani M, Muratorio A: Type 1 fiber 

abnormalities in skeletal muscle of patients with 

hypertrophic and dilated cardiomyopathy: evidence of 

subclinical myogenic myopathy. J Am Coll Cardiol 1989; 14; 

1464-73 I.F. 11.054 

- 4)Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, 

Bottazzo GF, McKenna WJ: Novel organ-specific circulating 

cardiac autoantibodies in dilated cardiomyopathy. J Am Coll 

Cardiol 1990; 15: 1527-34 I.F. 11.054 

- 5)Caforio ALP, Stewart JT, Bonifacio E, M Burke, Davies 

MJ, McKenna WJ, Bottazzo GF: Inappropriate Major 

Histocompatibility Complex expression on cardiac tissue in 

3


dilated cardiomyopathy. Relevance for autoimmunity? J 

Autoimmun 1990; 3: 187-200 I.F. 3.391 

- 6)McKenna WJ, Caforio ALP: What is myocarditis? In Shaw 

D, Hampton J, editors, Medicine International. Oxford: 

Medicine Education (International) Ltd 1989; 67: 2801 

- 7) Caforio ALP, Stewart JT, McKenna WJ: Idiopathic dilated 

cardiomyopathy. Rational treatment awaits better 

understanding of pathogenesis. Brit Med J 1990; 300: 

890-91 I.F. 9.723 

- 8) Caforio ALP, Bottazzo GF, McKenna WJ, Counihan PJ, 

Burke M, Davies MJ, Pepper JR: Class II Major 

Histocompatibility Complex Antigens on cardiac 

endothelium: an early biopsy marker of rejection in the 

transplanted human heart. Transplant P 1990; 22: 

1830-1833. 

- 9) Caforio ALP: Miocardiopatia dilatativa: quadro clinico, 

ipotesi patogenetiche ed implicazioni terapeutiche. Primary 

Cardiology 1990; 5 (3): 185-189 

- 10) Frennaux MP, Counihan PJ, Caforio ALP, Chikamori T, 

McKenna WJ: Abnormal blood pressure response in 

hypertrophic cardiomyopathy. Circulation 1990; 82: 

1995-2002 I.F. 12.755 

- 11) Caforio ALP, McKenna WJ: Dilated cardiomyopathy: 

chronic viral infection or autoimmune disease? A critical 

view of the viral and the autoimmune hypothesis. Indian 

Heart Journal 1990; 42:399-402 

- 12) Stewart JT, Caforio ALP, McKenna WJ: Ventricular 

arrhythmias in dilated cardiomyopathy. L' Information 

Cardiologique 1990: 14: 798-801 

- 13) Caforio ALP, Wagner R, Gill JR, Bonifacio E, Bosi E, 

Miles A, McKenna WJ, Bottazzo GF: Organ-specific cardiac 

autoantibodies: new serological markers for systemic 

hypertension in autoimmune polyendocrinopathy. Lancet 

1991 337:1111-15 

- 14) Alfonso F, Caforio ALP, Del Toro J, Torrecilla E, Rey M, 

De Rabago P: Right ventricular dilated cardiomyopathy 

associated with primary biliary cirrhosis. Eur Heart J 

1991;12: 1240-43. I.F. 7.924 

- 15) Caforio ALP, Bonifacio E, Keeling PJ, Grazzini M, 

Schiaffino S, Bottazzo GF, McKenna WJ: Cardiomiopatia 

dilatativa idiopatica: infezione virale persistente o malattia 

autoimmune organo-specifica? Processo alle due ipotesi 

patogenetiche maggiori. Giornale Italiano di Cardiologia 

1992; 22: 63-72 

- 16) Keeling PJ, Caforio ALP: The assessment of viral and 

immune mediated pathogenesis in dilated cardiomyopathy. 

In Oto A, editor, Current practice of cardiology (Proceedings 

of the 4th annual Meeting of the Mediterranean association 

4


of Cardiology and Cardiac Surgery and the 3rd International 

Symposium on Cardiac Pacing and Electrophysiology. 

September 23-30, 1990. Antalya, Turkey) , Mount Kisco: 

Futura media services, inc. 1991; 69-78. 

- 17) Caforio ALP, Goodwin JF: Current insights into the 

pathogenesis and treatment of dilated cardiomyopathy. 

Primary Cardiology 1992; 18: 37-48. 

- 18) Caforio ALP, Grazzini M, Mann JM, Keeling PJ, 

Bottazzo GF, McKenna WJ, Schiaffino S: Identification of 

the a and b myosin heavy chain isoforms as major 

autoantigens in dilated cardiomyopathy. Circulation 1992; 

85: 1734-42 I.F. 12.755 

- 19) Caforio ALP, Martinetti M, Bonifacio E, Gavazzi A, 

Graziano G, Cuccia MC, Lorini R, McKenna WJ, Bottazzo 

GF: Idiopathic dilated cardiomyopathy: lack of association 

between organ-specific cardiac antibodies and HLA-DR 

antigens. Tissue Antigens 1992; 39 (5): 236-40 I.F. 2.245 

- 20) Jennison SH, Caforio ALP, Fashola T, Riley S, Holt 

DW. The use of interleukin-2 receptor levels in cardiac 

transplant recipients. (letter) Transplantation 1992; 53 (4): 

954-55 I.F. 3.691 

- 21) Keeling PJ, Jeffrey S, Caforio ALP, Taylor R, Bottazzo 

GF, Davies MJ, McKenna WJ: Similar prevalence of 

enteroviral genome within the myocardium from patients 

with idiopathic dilated cardiomyopathy and controls by the 

polymerase chain reaction. Br Heart J 1992; 68: 554-559 

I.F. 4.141 

- 22) Martinetti M, Dugoujon JM, Caforio ALP, Schwarz G, 

Gavazzi A, Graziano G, Arbustini E, Lorini R, McKenna WJ, 

Bottazzo GF, Cuccia M. HLA antigens and immunoglobulin 

polymorphisms in idiopathic dilated cardiomyopathy. Hum 

Immunol 1992; 35: 193-199. I.F. 2.901 

- 23) Zachara E, Caforio ALP, Carboni GP, Pellegrini A, 

Pompili A, Del Porto G, Sciarra A, Bosman C, Boldrini R, 

Prati Pl, McKenna WJ. Familial aggregation of idiopathic 

dilated cardiomyopathy: clinical features and pedigree 

analysis in 14 families. Br Heart J 1993; 69: 129-35. I.F. 

4.141 

- 24) Keeling PJ, Lukaszyk A, Poloniecki J, Caforio ALP, 

Davies MJ, Booth JC, McKenna WJ: A prospective 

case-control study of antibodies to Coxsackie-B virus in 

idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1994; 

23: 593-8 I.F. 11.054 

- 25) Caforio ALP, Keeling PJ, Zachara E, Mestroni L, 

Camerini F, Mann JM, Bottazzo GF, McKenna WJ. 

Evidence from family studies for autoimmunity in dilated 

cardiomyopathy. Lancet 1994; 344: 773-777 I.F. 28.638 

- 26) Caforio ALP, Keeling PJ, McKenna WJ: Autoimmune 

pathogenesis of dilated cardiomyopathy. An overview. 

5


Cardioscopies 1995; 29: 454-582 

- 27) Schiaffino S, Caforio ALP, Di Lisa F. Biochimica e 

biologia molecolare nello studio della biopsia 

endomiocardica. In Baroldi G, Thiene G: "Biopsia 

endomiocardica. Testo-atlante", Piccin Ed, Padova 1996: 

321-325 

- 28) Livi U, Caforio ALP, Grassi G, Boffa GM, Gambino A, 

Milano A, Bianco R, Casula R, Thiene G, Casarotto D. 

Mid-term results of heart transplantation in diabetic patients. 

J Cardiovasc Surg 1994; 35 (Suppl 1 to No. 6): 115-8. I.F. 

1.570 

- 29) Milano A, Livi U, Caforio ALP, Bianco R, Casula R, 

Gambino A, Feltrin G, Legittimo A, Angelini A, Thiene G, 

Casarotto D. The behaviour of "Grade 2" ISHLT cardiac 

rejection. Transplant P 1994; 26(5): 2724 I.F. 1.027 

- 30) Livi U, Milano A, Caforio ALP, Grassi G, Feltrin G, Boffa 

GM, D'Agnolo A, Bianco R, Angelini A, Thiene G, Casarotto 

D. Influence of rejection on late graft function after heart 

transplantation. Transplant P 1994; 26 (5): 2727-28 I.F. 

1.027 

- 31) Caforio ALP: Role of autoimmunity in dilated 

cardiomyopathy. Br Heart J 1994; 72 (Supplement) 

S30-S34. I.F. 4.141 

- 32) Marcolongo R, Laveder F, Caforio ALP. Cuore e vasi 

nelle malattie da alterata immunoregolazione. In Dalla Volta 

S, ed. Malattie del cuore e dei vasi. Milano: McGraw-Hill, 

1996: 617-39 

- 33) Livi U, Caforio ALP, Grassi G, Boffa GM, Barchitta A, 

Gambino A, Thiene G, Casarotto D. Heart transplantation 

for end-stage valvular disease. Transplant P 1995; 27 (1): 

1305-06 I.F1.027 

- 34) Keeling PJ, Gang Y, Smith G, Seo H, Bent SE, Murday 

V, Caforio ALP, McKenna WJ. Familial dilated 

cardiomyopathy in the United Kingdom. Br Heart J 1995; 73 

(5): 417-21 I.F. 4.141 

- 35) Caforio ALP, Jonathan H Goldman, M. Kamran Baig, 

Keeling PJ, Bottazzo GF, McKenna WJ: Organ-specific 

cardiac autoantibodies in dilated cardiomyopathy-an 

update. Eur Heart J 1995; 16 (Suppl. 0): 68-70 I.F. 7.924 

- 36) Bilinska ZT, Caforio ALP, Grzybowski J, Michalak E, 

Kusmierczyc- Droszcz B, Goldman JH, Haven LH, 

Rydlewska-Sadowska W, McKenna WJ, Ruzyllo W. 

Organ-specific cardiac autoantibodies in dilated 

cardiomyopathy: frequency and clinical correlates in Polish 

patients. Eur Heart J 1995; 16: 1907-11. I.F. 7.924 

- 37) Livi U, Caforio ALP, Boffa GM, Tursi V, Thiene G, 

Casarotto D. Mid-term results of heart transplantation for 

end-stage valvular disease. Eur J Cardio-Thorac 1995; 9: 

6


521-25. I.F. 2.011 

- 38) Keeling PJ, Goldman JH, Slade AKB, Elliott PM, 

Caforio ALP, Poloniecki J, McKenna WJ. Prognosis of 

idiopathic dilated cardiomyopathy at a referral center. J 

Cardiac Failure 1995; 1 (5): 1-9. I.F. 3.067 

- 39) Goldman JH, Warraich RS, Keeling PJ, Redwood S, 

Baig KM, Elliott PM, Dalla Libera L, Sanderson JE, Caforio 

ALP, McKenna WJ. Autoimmunity to a-myosin in a subset 

of patients with idiopathic dilated cardiomyopathy. Br Heart 

J 1995; 74: 598-603 I.F. 4.141 

- 40) Livi U, Caforio ALP, Tursi V, Boffa GM, Borrelli MR, 

Bauce B, Thiene G, Casarotto D. Donor age greater than 

50 years does not influence mid-term results of heart 

transplantation. Transplant P 1996; 28 (1): 91-92 I.F. 1.027 

- 41) Caforio ALP, Jonathan H Goldman, Aldwyn J Haven, M. 

Kamran Baig, McKenna WJ: Evidence for autoimmunity to 

myosin and other heart-specific autoantigens in patients 

with dilated cardiomyopathy and their relatives. Int J Cardiol 

1996; 54 (2): 157-63 I.F. 2.878 

- 42) Milano A, Caforio ALP, Livi U, Bauce B, Angelini A, 

Casarotto D, Thiene G. Evolution of focal moderate (ISHLT 

grade 2) rejection of the cardiac allograft. J Heart Lung 

Transpl 1996; 15 (5): 456-60 I.F. 3.087 

- 43) Caforio ALP, McKenna WJ: Recognition and optimum 

management of myocarditis. Drugs 1996; 52 (4): 515-25 

I.F. 3.726 

- 44) Bilinska ZT, Caforio ALP, Kusmierczyc-Droszcz B, 

Michalak E, Grzybowski J, Goldman JH, Haven AJ, 

Rydlewska-Sadowska W, McKenna WJ, Ruzyllo W. 

Increased frequency of organ-specific cardiac antibodies in 

healthy relatives of patients with dilated cardiomyopathy: 

evidence for autoimmunity in Polish families. Clin Cardiol 

1996; 19: 794-98 I.F. 1.067 

- 45) Thiene G, Angelini A, Basso C, Caforio ALP, Calabrese 

F, Corrado D, Rampazzo A, Valente M. Patologia e 

patogenesi della cardiomiopatia aritmogena del ventricolo 

destro. In Delise P, "Atti del Convegno Nazionale di 

Cardiologia dello Sport. Confini tra normalita' e patologia 

nel cuore dello sportivo", Venezia-S. Giuliano, 1-2 

Novembre 1996: 147-49. 

- 46) Caforio ALP: Autoimmunity in myocarditis and dilated 

cardiomyopathy. In Puddu PE, Bing RJ, Campa PP, 

Poole-Wilson PA, editori: Congestive heart failure: from 

basic science to therapeutics. Cardioricerca Ed, Roma 

1997: 153- 178. 

- 47) Betterle C, Spadaccino A.C., Pedini B, Caforio ALP. 

Autoanticorpi nelle malattie autoimmuni del muscolo 

scheletrico, della giunzione neuro-muscolare, e del cuore. 

In Betterle C, Gli autoanticorpi. Manuale-Atlante a colori di 

7


diagnostica. Padova: Piccin Editore, 1997: 313-37. 

- 48) Caforio ALP, Goldman JH, Baig KM, Haven AJ, Dalla 

Libera L, Keeling PJ, McKenna WJ. Cardiac autoantibodies 

in dilated cardiomyopathy become undetectable with 

disease progression. Heart 1997; 77: 62-67 I.F. 4.141 

- 49) Caforio ALP, Goldman JH, Haven AJ, Baig KM, Dalla 

Libera L, McKenna WJ. Circulating cardiac autoantibodies 

as markers of autoimmunity in clinical and biopsy-proven 

myocarditis. Eur Heart J 1997; 18: 270-75 I.F. 7.924 

- 50) Caforio ALP: Postviral autoimmune heart disease: fact 

or fiction? Eur Heart J 1997; 18: 1051-55 I.F. 7.924 

- 51) Hossein-Nia M, Baig MK, Goldman JH, Keeling PJ, 

Caforio ALP, Holt DW, McKenna WJ. Creatine kinase 

isoforms as circulating markers of deterioration in idiopathic 

dilated cardiomyopathy. Clin Cardiol 1997; 20 (1): 55-60 I.F. 

1.067 

- 52) Caforio ALP, Bauce B, Boffa G M, De Cian F, Angelini 

A, Melacini P, Razzolini R, Fasoli G, Chioin R, Schiaffino S, 

Thiene G, Dalla Volta S. Autoimmunity in myocarditis and 

dilated cardiomyopathy: cardiac autoantibody frequency 

and clinical correlates in a patient series from Italy. G Ital 

Cardiol 1997; 227: 106-112. 

- 53) Livi U, Caforio ALP, Guzzi G, Feltrin G, Boffa GM, 

Angelini A, Casarotto D. Impact of organ preservation 

techniques in the era of donor pool expansion. Transplant P 

1997; 29: 3382-83. I.F. 1.027 

- 54) Baig MK, Salomone O, Caforio ALP, Goldman JH, 

Amuchastegui M, Caiero T, McKenna WJ: Human 

Chagasic disease is not associated with antiheart humoral 

response. Am J Cardiol 1997; 79: 1135-37 I.F. 3.603 

- 55) Baig MK, Goldman JH, Caforio ALP, Coonar AS, 

Keeling PJ, McKenna WJ. Familial dilated cardiomyopathy: 

cardiac abnormalities are common in asymptomatic 

relatives and may represent early disease. J Am Coll 

Cardiol 1998; 31(1): 195-201. I.F. 11.054 

- 56) Caforio ALP, Goldman JH, Haven AJ, Baig MK, 

McKenna WJ: Organ- specific cardiac autoantibodies in 

dilated cardiomyopathy: pathogenetic implications. 

Proceedings of the 2nd Florence meeting on "Advances in 

cardiomyopathies". Springer Verlag 1998; 101-106 

- 57) Livi U, Caforio ALP, Tursi V, Brombin M, Feltrin G, 

Angelini A, Casarotto D. Heart transplantation in patients 

with neoplastic disease. G Ital Cardiol 1997; 27: 11-12 . 

- 58) Baig K, Mahon N, McKenna WJ, Caforio ALP, Bonow 

R, Francis G, Gheorghiade M. The pathophysiology of 

advanced heart failure. Am Heart J 1998; 135(6 Pt 2Su): 

S216-S230. I.F. 3.649 

- 59) Livi U, Caforio ALP, Gambino A, Tursi V, Milanesi O, 

8


Stellin G, Angelini A, Casarotto D. Cyclosporine-based 

steroid-free therapy in pediatric heart transplantation: long 

term results. Transplant P 1998; 30 (5): 1975-76 I.F 1.027 

- 60) Caforio ALP, Tursi V, Brombin M, Feltrin G, Angelini A, 

Livi U. Heart transplantation in patients with neoplastic 

disease. Transplant P 1998; 30 (5) 1928 I.F. 1.027 

- 61) Currie PF, Goldman JH, Caforio ALP, Jacob AJ, Baig 

KM, Brettle RP, Haven AJ, Boon NA, McKenna WJ. 

Evidence of cardiac autoimmunity in HIV related heart 

muscle disease. Heart 1998; 79 (6): 599-604. I.F. 4.141 

- 62) Livi U, Caforio ALP, Feltrin G, Gambino A, Milanesi O, 

Casarotto D. Organ and somatic growth after heart 

transplantation. In Livi U, Thiene G, Casarotto D, eds: Heart 

transplantation in Italy. Masson, Milano 1999: 191-195. 

- 63) de Leeuw N, Melchers WJG, Ruiter DJ, Caforio ALP, 

Balk AHMM, de Jonge N, Galama JMD. Autoimmune 

markers are undetectable in end-stage idiopathic dilated 

cardiomyopathy. J Clin Pathol 1999; 52: 739-43 I.F. 2.426 

- 64) Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda 

A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio ALP, 

McKenna WJ, Falaschi A, Giacca M, Camerini F, and the 

Heart Muscle Disease Study Group. Familial dilated 

cardiomyopathy: evidence for genetic, phenotypic and 

etiologic heterogeneity. J Am Coll Cardiol 1999; 34 (1): 

181-90 I.F. 11.054 

- 65) Caforio ALP. Le miocarditi. G Ital Cardiol 1999; 29 (10): 

1169-70. 

- 66) Belloni-Fortina A, Caforio ALP, Piaserico S, Alaibac 

MSA, Tona F, Feltrin G, Livi U, Peserico A. Skin cancer in 

heart transplant recipients: frequency and risk factor 

analysis. J Heart Lung Transplant 2000; 19 (3): 249-55. I.F. 

3.087 

- 67) Caforio ALP, Belloni-Fortina A, Piaserico S, Alaibac 

MSA, Tona F, Feltrin G, Pompei E, Testolin L, Gambino A, 

Dalla Volta S, Thiene G, Casarotto D, Peserico A. Skin 

cancer in heart transplant recipients: risk factor analysis 

and relevance of immunosuppressive therapy. Circulation 

2000; 102 (Suppl III): III-222-III-227. I.F. 12.755 

- 68) Livi U, Caforio ALP. Heart donor management and 

expansion of current selection criteria. J Heart Lung 

Transplant 2000; 19 (8S): S43-S48. I.F. 3.087 

- 69) Buda A, Caforio ALP, Calabrese F, Fagiuoli S, Pevere 

S, Livi U, Naccarato R, Burra P. Lymphoproliferative 

disorders in heart transplant recipients: role of hepatitis C 

virus (HCV) and Epstein-Barr (EBV) infection. Transplant 

Int 2000; 13 (Suppl 1): S402-405. I.F. 2.3 

- 70) Melacini P, Gambino A, Caforio ALP, Bressan M, 

Valente ML, Angelini A, Fanin M, Thiene G, Angelini C, 

9


Casarotto D, Danieli GA, Dalla Volta S. Heart 

transplantation in patients with end-stage cardiomyopathy : 

molecular –biochemical defects on cardiac and skeletal 

muscle. Transplant P 2001:33; 1596-99 I.F. 1.027 

- 71) Caforio ALP, Belloni Fortina A, Gambino A, Piaserico S, 

Feltrin G, Tona F, Pompei E, Testolin L, Gai F, Angelini A, 

Casarotto D, Peserico A. High rejection score in the first 

year and risk of skin cancer in heart transplantation. 

Transplant P 2001:33;1608-09 I.F. 1.027 

- 72) Caforio ALP, Gambino A, Belloni Fortina A, Piaserico S, 

Scarpa E, Feltrin G, Tona F, Pompei E, Tonin E, Amadori 

G, Thiene G, Dalla Volta S, Peserico A, Casarotto D. 

Monoclonal gammopathy in heart transplantation: risk factor 

analysis and relevance of immunosuppressive load. 

Tranplant P 2001:33;1583-84 I.F. 1.027 

- 73) Maraglino G, Caforio ALP. Complicanze cardiologiche 

nei trapianti d’organo. In Naccarato R, Burra P, ed: 

Complicanze mediche nei trapianti d’organo. Piccin, 

Padova 2001; 25-40. 

- 74) Caforio ALP, Gambino A, Tona F, Feltrin G, Marchini F, 

Pompei E, Testolin L, Angelini A, Dalla Volta S, Casarotto 

D. Sulfinpyrazone reduces Cyclosporine A levels: a new 

drug interaction in heart transplant recipients. J Heart Lung 

Transplant 2000; 19 (12): 1205-1208. I.F. 3.087 

- 75) Dall’Amico R, Montini G, Murer L, Andreetta B, 

Zacchello G, Gambino A, Feltrin G, Caforio ALP, Tursi V, 

Livi U. Extracorporeal photochemotherapy after cardiac 

transplantation : a new therapeutic approach to allograft 

rejection. Int J Artif Organs 2000; 23 (1): 49-54. I.F. 1.277 

- 76) Caforio ALP, Goldman JH, Baig KM, Mahon NJ, Haven 

AJ, Souberbielle BE, Holt D W, Dalgleish AJ, McKenna WJ. 

Elevated serum levels of soluble interleukin-2 receptor, 

neopterin and b2 -microglobulin in idiopathic dilated 

cardiomyopathy: relation to disease severity and 

autoimmune pathogenesis. Eur J Heart Fail 2001; 3 (2): 

155-163 I.F. 2.986 

- 77) Caforio ALP, Mahon NJ, McKenna WJ. Cardiac 

autoantibodies to myosin and other heart-specific 

autoantigens in myocarditis and dilated cardiomyopathy. 

Autoimmunity, (special issue on “Update on Cardiac 

Autoimmunity”). 2001; 34 (3):199-204 I.F. 2.887 

- 78) Gambino A, Testolin G, Gerosa G, Feltrin G, Caforio 

ALP, Iacona GM, Spagna E, Casarotto D. New trend s in 

transplantation. Tranplant P 2001:33;1583-84 I.F. 1.027 

- 79) Caforio ALP , Betterle C. Malattie autoimmuni e 

immunomediate del cuore. In Betterle C, Le malattie 

autoimmuni. Padova: Piccin Editore, 2001: 353-67. 

- 80) Boffa GM, Caforio ALP, Livi U. Trapianto cardiaco. In 

Dalla Volta S, ed. Manuale delle malattie del cuore e 

10


dell’aorta. Seconda Ed.Milano: McGraw-Hill, 2001:273-282 

- 81) Marcolongo R, Laveder F, Rigoli AM, Caforio ALP. 

Cuore e vasi nelle malattie autoimmuni e da alterata 

immunoregolazione. In Dalla Volta S, ed. Manuale delle 

Malattie del cuore e dell’aorta. Seconda Ed.Milano: 

McGraw-Hill, 2001:723-732 

- 82) Caforio ALP, Tona F, Boffa GM, Daliento L, Bellotto F, 

Maddalena F, Ramondo A, Chioin R, Calabrese F, Angelini 

A, Nava A, Thiene G. Indicazioni allargate alla biopsia 

endomiocardica. In Cardiologia 2001. Atti del XXXV 

Convegno internazionale del Dipartimento Cardiologico A. 

De Gasperis, Milano, 24-28 Settembre 2001:258-264 

- 84) Mahon NG, Madden B, Caforio ALP, Haven AJ, Elliott 

PM, Keogh BE, Davies MJ, McKenna WJ. 

Immunohistochemical evidence of myocardial disease in 

apparently healthy relatives of patients with dilated 

cardiomyopathy. J Am Coll Cardiol 2002; 39 (3): 455-62 I.F. 

11.054 

- 85) Caforio ALP, Mahon NJ, Tona F, McKenna WJ. 

Circulating cardiac autoantibodies in dilated 

cardiomyopathy and myocarditis: pathogenetic and clinical 

significance. European Journal of Heart Failure. 2002; 4 (4): 

411-17 I.F. 2.986 

- 86) Daliento L, Calabrese F, Tona F, Caforio ALP, Tarsia 

G, Angelini A, Thiene G. Successful treatment of 

Enterovirus-induced myocarditis with interpheron alpha. J 

Heart Lung Transplant 2003; 22: 214-17 I.F. 3.087 

- 87) Mahon NG, Caforio ALP, McKenna WJ. Abnormal 

cellularity in asymptomatic relatives of patients with 

idiopathic dilated cardiomyopathy (letter) J Am Coll Cardiol 

2003; 41 (4): 709 I.F. 11.054 

- 88) Caforio ALP, Mahon NG, McKenna WJ. 

Immunosuppressive treatment in familial dilated 

cardiomyopathy with biopsy-proven intramyocardial 

inflammation? (letter) J Am Coll Cardiol 2003: 41 (1):169-71 

IF. 11.054 

- 89) Fagiuoli S, Pevere S, Minniti F, Livi U, Caforio ALP, 

Naccarato R, Chiaramonte M. Natural leucocyte interferon 

alfa for the treatment of chronic hepatitis in heart transplant 

recipients. Transplantation 2003: 75 (7): 982-86 I.F. 3.641 

- 90) Caforio ALP, Tona F, McKenna WJ. Organ-specific 

autoimmunity involvement in cardiovascular disease. In 

Doria, Pauletto P, eds. The heart in systemic autoimmune 

diseases. New York: Elsevier, 2004 1: 19-39 

- 91) Caforio ALP, Tona F, Belloni-Fortina A, Angelini A, 

Piaserico S, Gambino A, Feltrin G, Ramondo A, Valente 

ML, Iliceto S, Thiene G, Gerosa G. Immune and 

nonimmune predictors of cardiac allograft vasculopathy: 

multivariate risk factor analysis and role of 

11


immunosuppression. Am J Transplant 2004: 4: 962-70 I.F. 

6.423 

- 92) Belloni-Fortina A, Piaserico S, Caforio ALP, Abeni D, 

Alaibac M, Angelini A, Iliceto S, Peserico A. 

Immunosuppressive level and other risk factors for basal 

cell carcinoma and squamous cell carcinoma in heart 

transplant recipients. Arch Dermatol 2004 140: 1079-85 I.F. 

2.845 

- 93) Caforio ALP, Tona F, Piaserico S, Gambino A, Feltrin 

G, Belloni Fortina A, Angelini A, Alaibac M, Bontorin M, 

Calzolari D, Peserico A, Thiene G, Iliceto S, Gerosa G. C2 

is superior to C0 as predictor of renal toxicity and rejection 

risk profile in stable heart transplant patients. Transplant Int 

2005: 18: 116-124 I.F. 2.300 

- 94) Tona F, Caforio ALP, Piaserico S, Bontorin M, De 

Simone G, Leone MG, Belloni Fortina A, Gambino A, Feltrin 

G, Calzolari D, Angelini A, Peserico A, Thiene G, Gerosa G, 

Iliceto S. Abnormal total ejection isovolume index as early 

non-invasive marker of chronic cardiac allograft dysfunction 

in heart transplantation. Transplant Int 2005: 18: 303-308 

I.F. 2.300 

- 95) Belloni Fortina A, Piaserico S, Alaibac M, Caforio ALP, 

Brandolisio L, Zacchello G, Zanon G, Zancan L, Peserico A. 

Skin disorders in patients transplanted in childhood. 

Transplant Int 2005: 18: 360-365 I.F. 2.300 

- 96) Boffa GM, Caforio ALP, Gambino A, Tona F, Gerosa G. 

Trapianto cardiaco. In Dalla Volta S, Daliento L, Razzolini 

R, eds. Manuale delle malattie del cuore e dei vasi. Terza 

ed. Milano: McGraw-Hill, 2005: 263-271 

- 97) Marcolongo R, Carmello R, Tona F, Caforio ALP. Cuore 

e vasi nelle malattie autoimmuni e altre patologie 

immunomediate. In Dalla Volta S, Daliento L, Razzolini R, 

eds. Manuale delle Malattie del cuore e dei vasi. Terza ed. 

Milano: McGraw-Hill, 2005: 653-669 

- 98) Melacini P, Boffa GM, Nava A, Tona F, B Bauce, 

Caforio ALP. Malattie del miocardio. In Dalla Volta S, 

Daliento L, Razzolini R, eds. Manuale delle malattie del 

cuore e dei vasi. Terza ed. Milano: McGraw-Hill, 2005: 

447-472 

- 99) Caforio ALP, Mahon NJ, McKenna WJ. Clinical 

implications of anti-cardiac immunity in dilated 

cardiomyopathy. In Ernst Schering Research Foundation 

Workshop 55. Editors: HP Schultheiss, JF Kapp, Grotzbach 

G. Chronic viral and inflammatory cardiomyopathy. Berlin: 

Springer-Verlag, 2005: 169-93 

- 100) Mahon NG, Murphy RT, MacRae C, Caforio ALP, 

Elliott PM, McKenna WJ. Echocardiographic screening in 

asymptomatic relatives of dilated cardiomyopathy patients 

reveals preclinical disease. Ann Intern Med, 2005; 

143;108-115 I.F. 15.516 

12


- 101) Caforio ALP, Daliento L, Angelini A, Bottaro S, Vinci A, 

Dequal G, Tona F, Iliceto S, Thiene G, McKenna WJ. 

Autoimmune myocarditis and dilated cardiomyopathy: focus 

on cardiac autoantibodies. Lupus, 2005; 14(9):652-5 I.F. 

2.248 

- 102) Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli 

G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, 

Caforio ALP, Bergantin A, Tombini V, Moreo A, Doria A, 

Shoenfeld Y, Livneh A. Idiopathic recurrent acute 

pericarditis: absence of familial Mediterranean fever 

mutations, new rheumatological diseases, HLA typing. 

Lupus, 2005; 14 (9):670-4 I.F. 2.248 

- 103) Nelson PN, Astley SJ, Roden D, Waldron E, Baig K, 

Caforio ALP, Koutetakis Y, Perera S, Spry C. 

Characterisation of Anti-Myosin Monoclonal Antibodies. 

Hybridoma 2005; 24(6):314-8 I.F. 0.294 

- 104) Tona F, Caforio ALP, Montisci R, Angelini A, Ruscazio 

M, Gambino A, Ramondo A, Thiene G, Gerosa G, Iliceto S. 

Coronary-flow reserve by contrast-enhanced transthoracic 

echocardiography: a new non invasive diagnostic tool for 

cardiac allograft vasculopathy. Am J Transplant, 2006; 

6:998-1003 I.F. 6.423 

- 105) Tona F, Caforio ALP, Montisci R, Gambino A, Angelini 

A, Ruscazio M, Toscano G, Feltrin G, Ramondo A, Gerosa 

G, Iliceto S. Coronary flow velocity pattern and 

coronary-flow reserve by contrast-enhanced transthoracic 

echocardiography predict long-term outcome in heart 

transplantation. Circulation, 2006; 114 (Suppl I): I49-I-55 

I.F. 12.755 

- 106) Caforio ALP, Tona F, Iliceto S. Cardiomiopatie e 

malattie del muscolo scheletrico. Cardiologia 2006, J 

Medical Books, Editors, Viareggio: 385-91 

- 107) Burra P, Buda A, Livi U, Rigotti P, Zanus G, Calabrese 

F, Caforio AL,MeninC, Canova D, Farinati F, Aversa LSM. 

Occurrence of post-transplant lymphoproliferative disorders 

among over thousand adult recipients: any role for hepatitis 

C infection? Eur J Gastroenterol Hepatol 2006; 18: 1065-70 

I.F. 1.830 

- 108) Caforio ALP, Mahon NG, Baig KM, F Tona, Murphy 

RT, Elliott PM, McKenna WJ. Prospective familial 

assessment in dilated cardiomyopathy: cardiac 

autoantibodies predict disease development in 

asymptomatic relatives. Circulation, 2007; 115: 76-83 I.F. 

12.755 

- 109) Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, 

Bottaro S, Ramondo A, Carturan E, Iliceto S, Thiene G, 

Daliento L. A prospective study of biopsy-proven 

myocarditis: prognostic relevance of clinical and 

etiopathogenetic features at diagnosis. Eur Heart J , 2007; 

28 (11):1326-33 I.F. 7.924 

13


- 110) Angelini A, Castellani C, Tona F, Gambino A, Caforio 

ALP, Feltrin G, Della Barbera M, Valente ML, Gerosa G, 

Thiene G. Continuous engraftment and differentiation of 

male recipient Y-Chromosome-positive cardiomyocytes in 

donor female human heart transplants. J Heart Lung 

Transplant, 2007; 26 (11):1110-18 I.F. 3.087 

- 111) Caforio ALP, Angelini A. Dilated cardiomyopathy and 

myocarditis: classification, pathological, clinical and 

autoimmune features. XII Congresso Nazionale 

FADOI,16-19 maggio 2007, Abstract Book; 119-121 

- 112) Caforio ALP, Tona F, Bottaro S, Vinci A, Daliento L, 

Thiene G, Iliceto S. Clinical implications of anti-heart 

autoantibodies in myocarditis and dilated cardiomyopathy. 

Autoimmunity 2008; 41 (1):35-45 I.F. 2.887 

- 113) Caforio ALP, Iliceto S. Genetically-determined 

myocarditis. Clinical presentation and immunological 

characteristics. Curr Opin Cardiol 2008; Cardiol 2008; 

23:219-26 I.F. 2.504 

- 114) Caforio ALP, Vinci A, Iliceto S. Anti-heart 

autoantibodies in familial dilated cardiomyopathy. 

Autoimmunity 2008; 41 (6):462-69 I.F. 2.887 

- 115) Tona F, Caforio ALP, Iliceto S. Microvascular 

dysfunction in left apical ballooning syndrome: Primary 

cause or secondary phenomenon? Eur J Echocardiogr. 

2007 ;8:411-2. 

- 116) Brambilla G, Brucato A, Adler Y, Bosetti M, Coppini P, 

Caforio ALP, Spodick D, Canesi B. Recurrent acute 

idiopathic pericarditis: rheumatologic therapy, 

autoantibodies and long term outcome. Reumatismo. 

2007;59:25-31 

- 117) Pahl E, Caforio ALP, Kuhn MA. Allograft 

vasculopathy:detection, risk factors, natural history, and 

treatment. In Canter CE, S, Kirklin JK, eds. Pediatric heart 

transplantation ISHLT monograph series, Volume 2. 

Philadelphia: Elsevier, 2007: 173-185; ISSN 1930-2134 

- 118) Caforio ALP, Tona F, Vinci A, Calabrese F, Ramondo 

A, L Cacciavillani, Corbetti F, Leoni L, Thiene G, Iliceto S, 

Angelini A. Acute biopsy-proven lymphocytic myocarditis 

mimicking Takotsubo cardiomyopathy. Eur J Heart Fail ; 

2009; 11:428-31 I.F. 2.986 

- 119) Osto E, Tona F, Angelini A, Montisci, R, Ruscazio, M, 

Vinci A, Tarantini G, Ramondo, A, Gambino G, Thiene G, 

Caforio A, Gerosa G, Iliceto S. Determinants of coronary 

flow reserve in heart transplantation: a study performed with 

contrast-enhanced echocardiography. J Heart Lung 

Transplant; 2009 ; 28 (5):453-60 I.F. 3.087 

- 120) Angelini A, Castellani C, Poli F, Benazzi E, 

Torregrossa G, Tona F, Gambino A, Caforio ALP, Feltrin G, 

Toscano G, Valente M, Thiene G, Gerosa G. 

14


Antibody-mediated rejection without acute graft dysfunction 

in adult ABO-compatible heart transplantation: a case of 

accommodation. J Heart Lung Transplant; 2008 

Dec;27(12):1357-60. I.F. 3.087 

- 121) Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, 

Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, 

Bailey KR, Cunningham MW, Dec GW; Giant Cell 

Myocarditis Treatment Trial Investigators. Usefulness of 

immunosuppression for giant cell myocarditis. Am J Cardiol 

2008 Dec 1;102(11):1535-9. I.F. 3.603 

- 122) Leone O, Rapezzi C, Sinagra G, Angelini A, Arbustini 

E, Bartoloni G, Basso C, Caforio ALP, Calabrese F, 

Coccolo F, d’Amati G, Maresi E, Milanesi O, Nodari S, Oliva 

F, Perkan A, Prandstraller D, Pucci A, Ramondo R, Silvestri 

F, Valente ML, Thiene G. Federazione Italiana di 

Cardiologia. Documento di consenso sulla biopsia 

endomiocardica promosso dall’Associazione per la 

Patologia Cardiovascolare Italiana. G Ital Cardiol 2009; 10 

(Suppl 1-9): 1-50. 

15

RETRIBUZIONE ANNUA LORDA RISULTANTE DAL CONTRATTO INDIVIDUALE 

Amministrazione: AZIENDA OSPEDALIERA DI PADOVA 

dirigente: ALIDA LINDA PATRIZIA CAFORIO 

incarico ricoperto: Staff - Cardiologia 

stipendio tabellare 

posizione parte 

fissa 

posizione parte 

variabile 

retribuzione di 

risultato 

altro* 

TOTALE ANNUO 

LORDO 

€ 0,00 € 0,00 € 0,00 € 0,00 € 0,00 € 0,00 

*ogni altro emolumento retributivo non ricompreso nelle voci precedenti 

16

curriculum vitae - Azienda Ospedaliera di Padova

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?